Remuneration Details - The remuneration details for supervisors from 2019 to 2024 are provided, with 徐建海 receiving RMB 378.41k in 2019, increasing to RMB 495.34k in 2021, and then decreasing to RMB 203.41k in 2022[3] - 陳潔's remuneration has shown a steady increase from RMB 245.61k in 2019 to RMB 520.83k in 2024, indicating a growth trend[3] - The company has not paid any remuneration to supervisors in their capacity as supervisors, as indicated in the announcement[3] Governance Structure - The board of directors is composed of both executive and non-executive members, ensuring a diverse governance structure[6] Disclosure Integrity - The announcement does not affect other information disclosed in the annual report, maintaining the integrity of previously reported data[4]
瑛泰医疗(01501) - 2024 - 年度业绩